Related Experiment Video
Updated: Mar 18, 2026
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Pilin Vaccination Stimulates Weak Antibody Responses and Provides No Protection in a C57Bl/6 Murine Model of Acute
Grace A Maldarelli1, Hanover Matz1, Si Gao2
1Department of Medicine, Division of Infectious Disease, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Insights
Vaccinating mice against Clostridium difficile Type IV pili (T4Ps) did not generate protective immunity. Further research is needed to explore anti-T4P vaccines against C. difficile infections.
Area of Science:
- Microbiology and Immunology
- Infectious Diseases
- Vaccine Development
Background:
- Clostridium difficile is a major cause of hospital-acquired infections, leading to significant healthcare costs.
- Type IV pili (T4Ps) are bacterial surface structures implicated in adhesion and colonization, making them potential vaccine targets.
- Developing a vaccine against C. difficile colonization factors could reduce disease incidence and spread.
Purpose of the Study:
- To investigate the potential of Type IV pili (T4Ps) from Clostridium difficile as vaccine targets.
- To determine if vaccination with pilins generates protective immunity against C. difficile challenge in a mouse model.
Main Methods:
- Immunization of C57Bl/6 mice with various pilins, individually or in combination.
- Measurement of anti-pilin antibody titers (serum and fecal IgG).
- Passive antibody transfer experiments followed by C. difficile challenge.
Main Results:
- Active immunization with pilins resulted in low anti-pilin antibody titers and failed to protect mice against C. difficile challenge.
- Passive transfer of anti-pilin antibodies achieved high serum IgG titers but undetectable fecal IgG titers, offering no protection.
- The observed low antibody responses may be attributed to the specific mouse strain used in the study.
Conclusions:
- Vaccination targeting Clostridium difficile Type IV pili (T4Ps) did not confer protection in the tested mouse model.
- Further investigation using alternative animal models is necessary to fully evaluate the efficacy of anti-T4P vaccines against C. difficile infection.
Abstract:
Clostridium difficile is the leading cause of nosocomial infections in the United States, adding billions of dollars per year to health care costs. A vaccine targeted against the bacterium would be extremely beneficial in decreasing the morbidity and mortality caused by C. difficile-associated disease; a vaccine directed against a colonization factor would hinder the spread of the bacterium as well as prevent disease. Type IV pili (T4Ps) are extracellular appendages composed of protein monomers called pilins. They are involved in adhesion and colonization in a wide variety of bacteria and archaea, and are putative colonization factors in C. difficile. We hypothesized that vaccinating mice with pilins would lead to generation of anti-pilin antibodies, and would protect against C. difficile challenge. We found that immunizing C57Bl/6 mice with various pilins, whether combined or as individual proteins, led to low anti-pilin antibody titers and no protection upon C. difficile challenge. Passive transfer of anti-pilin antibodies led to high serum anti-pilin IgG titers, but to undetectable fecal anti-pilin IgG titers and did not protect against challenge. The low antibody titers observed in these experiments may be due to the particular strain of mice used. Further experiments, possibly with a different animal model of C. difficile infection, are needed to determine if an anti-T4P vaccine would be protective against C. difficile infection.
